Prevalence of high‐risk HPV among marginalized urban women in India and its implications on vaccination: A cross sectional study

Objective To discover the prevalence and distribution of high‐risk human papilloma virus (HPV) subtypes in urban slums and their implications. Methods A cross‐sectional study was performed to discover prevalence and distribution of high‐risk HPV subtypes. We screened 956 women. Data were analyzed us...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of gynecology and obstetrics 2023-07, Vol.162 (1), p.176-182
Hauptverfasser: Vora, Kranti Suresh, Saiyed, Shahin, Joshi, Rajendra, Natesan, Senthilkumar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective To discover the prevalence and distribution of high‐risk human papilloma virus (HPV) subtypes in urban slums and their implications. Methods A cross‐sectional study was performed to discover prevalence and distribution of high‐risk HPV subtypes. We screened 956 women. Data were analyzed using SPSS v.25. Inclusion criterion was married women between 30 and 45 years of age. Exclusion criteria were women with known cervical cancer at the time of the survey or those who had undergone hysterectomy. Results Of the women, 32.47% were HPV positive and of these, about 84.50% were positive for high‐risk HPV. HPV type 6 (HPV 6) and HPV 11 were not seen in the population. After HPV 16 and HPV 18, type 58 was the most common variant seen in our study. Currently‐used vaccines in India do not cover HPV 58. Conclusion Knowing and understanding the distribution of high‐risk HPV are necessary for an effective strategy to eliminate cervical cancer from India. Deoxyribonucleic acid‐based HPV screening is a useful method along with vaccination to prevent cervical cancer. Synopsis High‐risk HPV prevalence is important and high‐risk HPV subtypes found in our study are different from those covered by current vaccines.
ISSN:0020-7292
1879-3479
1879-3479
DOI:10.1002/ijgo.14428